Tuesday, 18 Jun 2019

You are here

The RheumNow Week in Review – 18 August 2017

The RheumNow Week in Review discusses the past week's news, journal articles and highlights from RheumNow.com. This week's report includes new data on lupus survival, pediatric lupus guidelines from SHARE, room temperature storage of etanercept, over or under-testing by rheumatologists and failure of pain meds to treat pain.

  1. Lupus Survival improved in the 1990s; high-income countries have a  5-yr survival >95% in adults & kids; but low/middle-income countries have a lower survival in kids alone. https://buff.ly/2vV9vIJ 
  2. Study of Acute gout episodes : 26% had SF MSU & CPP crystals. CPP crystals in gout patients was assoc. with gout duration, CKD, erosive dz; not age https://buff.ly/2wdFbK9 
  3. RA and PsA (but not depression) were assoc. with increased risk of pre-term birth & preeclamsia. https://t.co/7ZHzNeQBWK
  4. Downside to steroids:  2 yrs of intraarticular  triamcinolone knee injx (vs PBO) caused more cartilage loss; but no diff in knee pain https://t.co/795WiSBhCA
  5. 26 yoF undergoing B/L hand/forearm transplants developed RA without prior hx of RA in either the donor or recipient https://t.co/Ih3kpvv89u
  6. SHARE SLE Guidelines Recommend Dx by SLICC, testing for complement defic., ENA, CXR, referral to a pediatric rheum https://t.co/4Zd5qSFtZD
  7. Study shows etanercept may be stored at conditions of 25°C±2°C (77F) for up to 1 month within expiry dates https://t.co/HMf7pcVudE
  8. One in three Rheumatoid arthritis patients fail to pick up Rx meds because of cost according to Natl RA Society in the UK. https://t.co/3DaqjLfhF4
  9. Tocilizumab in Scleroderma completed enrollment in phase III trial – it will be another yr till skin + lung results https://t.co/6QVGeDScbv
  10. How Much Testing is Enough? 
  11. No Evidence to Support Use of Gabapentinoids in Low Back Pain
  12. Marijuana Has Little Effect on Most Types of Pain
  13. Psoriatic Arthritis Patients with Comorbidities have Worse Disease and Poor Response
  14. Pegloticase Infusion Reactions Largely Seen in Non-Responders
Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

EULAR 2019- Day 4 Report

Saturday June 15th was the last half-day at EULAR 2019 but was highlighted by the “late-breaking” (LB) presentations that were presented from the podium and by poster.

Below are the top “LB” presentations from EULAR this year:

Understanding Non-arthritic Rheumatic iRAEs

A better understanding of rheumatic immune-related adverse event phenotypes beyond inflammatory arthritis has been furthered by work from three abstracts presented at EULAR 2019 in Madrid.

Ultrasound Reveals Which Anti-CCP Positive Patients Progress to Arthritis 

Power Doppler signal on baseline ultrasound exam may well help stratify anti-CCP positive patients with musculoskeletal symptoms but no clinical synovitis, according to data from the Leeds Institute of Rheumatic and Musculoskeletal Medicine presented at EULAR 2019.

EULAR 2019 – Day 3 Report

The third day of EULAR 2019 started with novel biologics, the efficacy of secukinumab in axial psoriatic arthritis, neurologic events with TNF inhibitors from the DANBIO database (OP0261), and neuropathy in SLE (OP0252), but above all this was a big poster day. Here are selected highlights from day 3 EULAR in Madrid.

RheumNow Podcast – EULAR 2019 Streamin' - (6.14.19)

Dr. Jack Cush reports from Madrid on several novel presentations from EULAR 2019.

1. Genovese Vagal nerve stimulator in RA

2. Low dose steroids in Hand OA